PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation

BioEssays

Volumn 39, Issue 10, 2017, Pages

  Hou, Sheng Qi ^a   Ouyang, Meng ^a   Brandmaier, Andrew ^a   Hao, Hongbo ^a   Shen, Wen H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

checkpoint; chromosome segregation; DNA replication; genome; mitotic spindle; PTEN

Indexed keywords

GAMMA TUBULIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLO LIKE KINASE 1; PTEN PROTEIN, HUMAN;

CHROMATIN; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CYTOKINESIS; DNA REPLICATION; DNA REPLICATION ORIGIN; FEEDBACK SYSTEM; G2 PHASE CELL CYCLE CHECKPOINT; GENE DUPLICATION; GENE FUNCTION; GENOMIC INSTABILITY; MITOSIS SPINDLE; MOUSE; NONHUMAN; PI3K/AKT SIGNALING; POLYPLOIDY; REPLISOME; REVIEW; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; SPINDLE POLE; STRESS; ANIMAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SPINDLE APPARATUS;

ANIMALS; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; DNA REPLICATION; GENOMIC INSTABILITY; HUMANS; PTEN PHOSPHOHYDROLASE; SPINDLE APPARATUS;

EID: 85029063787     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201700082     Document Type: Review

References (51)

1. Tomasetti C, Li L, Vogelstein B. 2017. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355: 1330–4.
2. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. 2009. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16: 475–86.
3. Levine MS, Bakker B, Boeckx B, Moyett J, et al. 2017. Centrosome amplification is sufficient to promote spontaneous tumorigenesis in mammals. Dev Cell 40: 313–22 e5.
4. Weaver RL, Limzerwala JF, Naylor RM, Jeganathan KB, et al. 2016. BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. Elife 5: pii: e16620.
5. Li J, Yen C, Liaw D, Podsypanina K, et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–7.
6. Steck PA, Pershouse MA, Jasser SA, Yung WK, et al. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–62.
7. Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375–8.
8. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, et al. 1999. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96: 2110–5.
9. Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M, et al. 1999. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res 59: 2318–23.
10. Sun H, Lesche R, Li DM, Liliental J, et al. 1999. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96: 6199–204.
11. Kandel ES, Skeen J, Majewski N, Di Cristofano A, et al. 2002. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22: 7831–41.
12. Puc J, Keniry M, Li HS, Pandita TK, et al. 2005. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7: 193–204.
13. Ginn-Pease ME, Eng C. 2003. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 63: 282–6.
14. Chung JH, Ginn-Pease ME, Eng C. 2005. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 65: 4108–16.
15. Liu JL, Sheng X, Hortobagyi ZK, Mao Z, et al. 2005. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol 25: 6211–24.
16. Chung JH, Eng C. 2005. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65: 8096–100.
17. Shen WH, Balajee AS, Wang J, H Wu, et al. 2007. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128: 157–70.
18. Bassi C, Ho J, Srikumar T, Dowling RJ, et al. 2013. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 341: 395–9.
19. He J, Kang X, Yin Y, Chao KS, et al. 2015. PTEN regulates DNA replication progression and stalled fork recovery. Nat Commun 6: 7620.
20. Feng J, Liang J, Li J, Li Y, et al. 2015. PTEN controls the DNA replication process through MCM2 in response to replicative stress. Cell Rep 13: 1295–303.
21. Wang G, Li Y, Wang P, Liang H, et al. 2015. PTEN regulates RPA1 and protects DNA replication forks. Cell Res 25: 1189–204.
22. van Ree JH, Nam HJ, Jeganathan KB, Kanakkanthara A, et al. 2016. Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol 18: 814–21.
23. He J, Zhang Z, Ouyang M, Yang F, et al. 2016. PTEN regulates EG5 to control spindle architecture and chromosome congression during mitosis. Nat Commun 7: 12355.
24. Zhang Z, Hou SQ, He J, Gu T, et al. 2016. PTEN regulates PLK1 and controls chromosomal stability during cell division. Cell Cycle 15: 2476–85.
25. Sun Z, Huang C, He J, Lamb KL, et al. 2014. PTEN C-terminal deletion causes genomic instability and tumor development. Cell Rep 6: 844–54.
26. Bubien V, Bonnet F, Brouste V, Hoppe S, et al. 2013. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50: 255–63.
27. Chen ZH, Zhu M, Yang J, Liang H, et al. 2014. PTEN interacts with histone H1 and controls chromatin condensation. Cell Rep 8: 2003–14.
28. Gong L, Govan JM, Evans EB, Dai H, et al. 2015. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure. Cell Cycle 14: 2323–32.
29. Iliopoulos D, Guler G, Han SY, Druck T, et al. 2006. Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett 232: 27–36.
30. Indiani C, O'Donnell M. 2006. The replication clamp-loading machine at work in the three domains of life. Nat Rev Mol Cell Biol 7: 751–61.
31. Sorensen CS, Syljuasen RG. 2012. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res 40: 477–86.
32. Godin SK, Sullivan MR, Bernstein KA. 2016. Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication. Biochem Cell Biol 94: 407–18.
33. Iyer DR, Rhind N. 2017. The intra-S checkpoint responses to DNA damage. Genes 8: 74.
34. Cortez D. 2005. Unwind and slow down: checkpoint activation by helicase and polymerase uncoupling. Genes Dev 19: 1007–12.
35. Zou L, Elledge SJ. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542–8.
36. Byun TS, Pacek M, Yee MC, Walter JC, et al. 2005. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev 19: 1040–52.
37. Suwaki N, Klare K, Tarsounas M. 2011. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol 22: 898–905.
38. McEllin B, Camacho CV, Mukherjee B, Hahm B, et al. 2010. PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. Cancer Res 70: 5457–64.
39. Mukherjee A, Karmakar P. 2013. Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells. Mol Carcinog 52: 611–8.
40. Petermann E, Orta ML, Issaeva N, Schultz N, et al. 2010. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 37: 492–502.
41. Ruff P, Donnianni RA, Glancy E, Oh J, et al. 2016. RPA stabilization of single-stranded DNA is critical for break-induced replication. Cell Rep 17: 3359–68.
42. Kang X, Song C, Du X, Zhang C, et al. 2015. PTEN stabilizes TOP2A and regulates the DNA decatenation. Sci Rep 5: 17873.
43. Broderick R, Niedzwiedz W. 2015. Sister chromatid decatenation: bridging the gaps in our knowledge. Cell Cycle 14: 3040–4.
44. Liu Y, Nielsen CF, Yao Q, Hickson ID. 2014. The origins and processing of ultra fine anaphase DNA bridges. Curr Opin Genet Dev 26: 1–5.
45. Liu XS, Song B, Elzey BD, Ratliff TL, et al. 2011. Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation. J Biol Chem 286: 35795–800.
46. Leonard MK, Hill NT, Bubulya PA, Kadakia MP. 2013. The PTEN-Akt pathway impacts the integrity and composition of mitotic centrosomes. Cell Cycle 12: 1406–15.
47. Prosser SL, Pelletier L. 2017. Mitotic spindle assembly in animal cells: a fine balancing act. Nat Rev Mol Cell Biol 18: 187–201.
48. Choi BH, Pagano M, Dai W. 2014. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle. J Biol Chem 289: 14066–74.
49. Li Z, Li J, Bi P, Lu Y, et al. 2014. Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state. Mol Cell Biol 34: 3642–61.
50. Combes G, Alharbi I, Braga LG, Elowe S. 2017. Playing polo during mitosis: PLK1 takes the lead. Oncogene in press, [Epub ahead of print]. https://doi.org/10.1038/onc.2017.113
51. Kritikou E. 2007. PTEN − a new guardian of the genome. Nat Rev Mol Cell Biol 8: 179.